CSIMarket
 


Cell Medx Corp.  (CMXC)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cell Medx's Working Capital Ratio

CMXC's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




CMXC Working Capital Ratio (Nov 30 2019)
II. Quarter
(Aug 31 2019)
I. Quarter
(May 31 2019)
IV. Quarter
(Feb 28 2019)
III. Quarter
(Nov 30 2018)
II. Quarter
Y / Y Current Liabilities Change 2.78 % -7.54 % 0.05 % 64.18 % 41.2 %
Y / Y Current Assets Change 328.4 % 759.79 % 318.17 % 162.1 % -64.13 %
Working Capital Ratio MRQ 0.32 0.37 0.18 0.14 0.08
Overall Ranking # # # # #
Seq. Current Liabilities Change 3.93 % 14.01 % -31.51 % 26.65 % -6.5 %
Seq. Current Assets Change -10.47 % 136.09 % -14.17 % 136.13 % 79.69 %



Working Capital Ratio second quarter 2019 Comment
Due to increase in Current Liabilities in the second quarter 2019, Working Capital Ratio fell to 0.32 below Cell Medx Corp. average.

Within Biotechnology & Drugs industry 3 other companies have achieved higher Working Capital Ratio than Cell Medx in second quarter 2019. While total ranking remained unchanged compare to previous quarter at no. .

Explain Working Capital Ratio
Where is CMXC most successful ?
Working Capital Ratio CMXC on the trailing twelve month basis
Working Capital Ratio second quarter 2019 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 4
Healthcare Sector # 6
Overall Market # 95


Working Capital Ratio Statistics
High Average Low
0.86 0.14 0
(May 31 2013)   (Nov 30 2014)




Financial Statements
Cell Medx's Current Liabilities $ 1 Millions Visit CMXC's Balance sheet
Cell Medx's Current Assets $ 0 Millions Visit CMXC's Balance sheet
Source of CMXC's Sales Visit CMXC's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingNov 30 2019, within Biotechnology & Drugs Industry Working Capital RatioNov 30 2019 MRQ Current AssetsNov 30 2019 MRQ Current Liabilities
Idera Pharmaceuticals Inc   0.85 $ 46.268  Millions$ 54.517  Millions
Orgenesis Inc   0.82 $ 25.979  Millions$ 31.579  Millions
Protalix Biotherapeutics Inc   0.81 $ 32.479  Millions$ 40.175  Millions
Azurrx Biopharma Inc   0.80 $ 3.449  Millions$ 4.286  Millions
Aptevo Therapeutics Inc   0.80 $ 29.995  Millions$ 37.513  Millions
Citius Pharmaceuticals, Inc.  0.80 $ 2.892  Millions$ 3.630  Millions
Sunwin Stevia International Inc   0.78 $ 18.473  Millions$ 23.716  Millions
Navidea Biopharmaceuticals Inc   0.76 $ 2.916  Millions$ 3.820  Millions
Conversion Labs Inc   0.71 $ 2.747  Millions$ 3.866  Millions
Agenus Inc  0.71 $ 86.536  Millions$ 122.209  Millions
Biopharmx Corp  0.59 $ 0.986  Millions$ 1.684  Millions
Cure Pharmaceutical Holding Corp   0.52 $ 6.188  Millions$ 11.836  Millions
Biovie Inc.  0.50 $ 0.554  Millions$ 1.115  Millions
Vistagen Therapeutics, Inc.  0.47 $ 1.382  Millions$ 2.937  Millions
Amyris Inc   0.46 $ 73.611  Millions$ 161.137  Millions
Intelgenx Technologies Corp   0.38 $ 3.220  Millions$ 8.447  Millions
Mctc Holdings, Inc.  0.35 $ 0.093  Millions$ 0.265  Millions
Petvivo Holdings, Inc.  0.33 $ 0.332  Millions$ 1.015  Millions
Outlook Therapeutics, Inc.  0.33 $ 6.541  Millions$ 20.100  Millions
Iterum Therapeutics Plc  0.32 $ 11.718  Millions$ 36.986  Millions
Cell Medx Corp.  0.32 $ 0.400  Millions$ 1.265  Millions
American Cryostem Corp  0.28 $ 0.572  Millions$ 2.020  Millions
Quest Patent Research Corp  0.25 $ 2.405  Millions$ 9.545  Millions
Pharmacyte Biotech Inc   0.21 $ 0.209  Millions$ 1.019  Millions
Qrons Inc   0.20 $ 0.123  Millions$ 0.631  Millions
Cardax Inc   0.20 $ 1.586  Millions$ 8.133  Millions
Brainstorm Cell Therapeutics Inc.  0.19 $ 3.360  Millions$ 17.654  Millions
Burzynski Research Institute Inc  0.15 $ 0.033  Millions$ 0.216  Millions
Artemis Therapeutics Inc   0.14 $ 0.022  Millions$ 0.157  Millions
Cytodyn Inc.  0.11 $ 3.245  Millions$ 29.702  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

UUUU's Profile

Stock Price

UUUU's Financials

Business Description

Fundamentals

Charts & Quotes

UUUU's News

Suppliers

UUUU's Competitors

Customers & Markets

Economic Indicators

UUUU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071